Lxbio Pharmaceuticals is a Pharmaceutical company that develops biopharmaceutical products for the treatment of diabetic foot infections.
Lxbio Pharmaceuticals has raised $6.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2024.
Lxbio Pharmaceuticals's investors include Explorer Investments.
Lxbio Pharmaceuticals is headquartered in Lisbon, Portugal.
Lxbio Pharmaceuticals is a Pharmaceutical company that develops biopharmaceutical products for the treatment of diabetic foot infections.
Lxbio Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lxbio Pharmaceuticals — Funding & Investors." VCBacked, March 11, 2024, https://www.vcbacked.co/company/lxbio-pharmaceuticals. Accessed August 14, 2026.
VCBacked. (2024). Lxbio Pharmaceuticals — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/lxbio-pharmaceuticals
{{cite web |title=Lxbio Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/lxbio-pharmaceuticals |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated